Logo image of HCO.PA

HIGH CO (HCO.PA) Stock Fundamental Analysis

Europe - EPA:HCO - FR0000054231 - Common Stock

4.02 EUR
+0.06 (+1.52%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

Overall HCO gets a fundamental rating of 5 out of 10. We evaluated HCO against 69 industry peers in the Media industry. HCO has an excellent financial health rating, but there are some minor concerns on its profitability. HCO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year HCO was profitable.
In the past year HCO had a positive cash flow from operations.
In the past 5 years HCO has always been profitable.
In the past 5 years HCO always reported a positive cash flow from operatings.
HCO.PA Yearly Net Income VS EBIT VS OCF VS FCFHCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1.2 Ratios

HCO has a Return On Assets (2.99%) which is comparable to the rest of the industry.
HCO has a Return On Equity (5.99%) which is comparable to the rest of the industry.
HCO's Return On Invested Capital of 4.90% is in line compared to the rest of the industry. HCO outperforms 47.06% of its industry peers.
HCO had an Average Return On Invested Capital over the past 3 years of 10.16%. This is above the industry average of 7.74%.
The last Return On Invested Capital (4.90%) for HCO is well below the 3 year average (10.16%), which needs to be investigated, but indicates that HCO had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.99%
ROE 5.99%
ROIC 4.9%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
HCO.PA Yearly ROA, ROE, ROICHCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 4.86%, HCO is doing good in the industry, outperforming 60.29% of the companies in the same industry.
In the last couple of years the Profit Margin of HCO has remained more or less at the same level.
HCO has a Operating Margin of 5.88%. This is comparable to the rest of the industry: HCO outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of HCO has declined.
HCO's Gross Margin of 45.18% is in line compared to the rest of the industry. HCO outperforms 42.65% of its industry peers.
In the last couple of years the Gross Margin of HCO has declined.
Industry RankSector Rank
OM 5.88%
PM (TTM) 4.86%
GM 45.18%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
HCO.PA Yearly Profit, Operating, Gross MarginsHCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

HCO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HCO has been reduced compared to 1 year ago.
Compared to 5 years ago, HCO has less shares outstanding
Compared to 1 year ago, HCO has an improved debt to assets ratio.
HCO.PA Yearly Shares OutstandingHCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Yearly Total Debt VS Total AssetsHCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

HCO has an Altman-Z score of 1.95. This is not the best score and indicates that HCO is in the grey zone with still only limited risk for bankruptcy at the moment.
HCO has a better Altman-Z score (1.95) than 66.18% of its industry peers.
The Debt to FCF ratio of HCO is 0.24, which is an excellent value as it means it would take HCO, only 0.24 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.24, HCO belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
HCO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, HCO belongs to the best of the industry, outperforming 98.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.24
Altman-Z 1.95
ROIC/WACC0.64
WACC7.61%
HCO.PA Yearly LT Debt VS Equity VS FCFHCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.42 indicates that HCO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.42, HCO is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that HCO should not have too much problems paying its short term obligations.
HCO has a better Quick ratio (1.42) than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
HCO.PA Yearly Current Assets VS Current LiabilitesHCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

The earnings per share for HCO have decreased strongly by -50.54% in the last year.
Measured over the past years, HCO shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.40% on average per year.
Looking at the last year, HCO shows a decrease in Revenue. The Revenue has decreased by -2.37% in the last year.
Measured over the past years, HCO shows a decrease in Revenue. The Revenue has been decreasing by -3.59% on average per year.
EPS 1Y (TTM)-50.54%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%-6.38%

3.2 Future

Based on estimates for the next years, HCO will show a decrease in Earnings Per Share. The EPS will decrease by -0.92% on average per year.
HCO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.43% yearly.
EPS Next Y-27.05%
EPS Next 2Y-9.01%
EPS Next 3Y-0.92%
EPS Next 5YN/A
Revenue Next Year-20.78%
Revenue Next 2Y-5.16%
Revenue Next 3Y-2.43%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCO.PA Yearly Revenue VS EstimatesHCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
HCO.PA Yearly EPS VS EstimatesHCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.36, the valuation of HCO can be described as correct.
HCO's Price/Earnings ratio is in line with the industry average.
HCO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 15.76 indicates a correct valuation of HCO.
HCO's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, HCO is valued a bit cheaper.
Industry RankSector Rank
PE 14.36
Fwd PE 15.76
HCO.PA Price Earnings VS Forward Price EarningsHCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HCO is valued cheaper than 91.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.99
EV/EBITDA -0.63
HCO.PA Per share dataHCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.01%
EPS Next 3Y-0.92%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.17%, HCO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.53, HCO pays a better dividend. On top of this HCO pays more dividend than 86.76% of the companies listed in the same industry.
HCO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.17%

5.2 History

The dividend of HCO has a limited annual growth rate of 5.90%.
Dividend Growth(5Y)5.9%
Div Incr Years1
Div Non Decr Years1
HCO.PA Yearly Dividends per shareHCO.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

92.75% of the earnings are spent on dividend by HCO. This is not a sustainable payout ratio.
HCO's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP92.75%
EPS Next 2Y-9.01%
EPS Next 3Y-0.92%
HCO.PA Yearly Income VS Free CF VS DividendHCO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Dividend Payout.HCO.PA Dividend Payout, showing the Payout Ratio.HCO.PA Dividend Payout.PayoutRetained Earnings

HIGH CO

EPA:HCO (10/17/2025, 7:00:00 PM)

4.02

+0.06 (+1.52%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)09-10 2025-09-10
Earnings (Next)10-15 2025-10-15
Inst Owners16.94%
Inst Owner ChangeN/A
Ins Owners16.32%
Ins Owner ChangeN/A
Market Cap82.25M
Analysts82.5
Price Target4.54 (12.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.17%
Yearly Dividend0.28
Dividend Growth(5Y)5.9%
DP92.75%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.33%
PT rev (3m)28.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.49%
EPS NY rev (3m)-12.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.51%
Revenue NY rev (3m)-17.91%
Valuation
Industry RankSector Rank
PE 14.36
Fwd PE 15.76
P/S 0.72
P/FCF 3.99
P/OCF 3.86
P/B 0.89
P/tB 2.24
EV/EBITDA -0.63
EPS(TTM)0.28
EY6.97%
EPS(NY)0.26
Fwd EY6.34%
FCF(TTM)1.01
FCFY25.05%
OCF(TTM)1.04
OCFY25.93%
SpS5.59
BVpS4.54
TBVpS1.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.99%
ROE 5.99%
ROCE 6.73%
ROIC 4.9%
ROICexc 81.59%
ROICexgc N/A
OM 5.88%
PM (TTM) 4.86%
GM 45.18%
FCFM 18.01%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
ROICexc(3y)33.2%
ROICexc(5y)64.31%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.94%
ROCE(5y)13.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y5.39%
ROICexc growth 5Y4.92%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.24
Debt/EBITDA 0.2
Cap/Depr 12.4%
Cap/Sales 0.63%
Interest Coverage 250
Cash Conversion 169.75%
Profit Quality 370.44%
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 1.95
F-Score7
WACC7.61%
ROIC/WACC0.64
Cap/Depr(3y)22.18%
Cap/Depr(5y)23.34%
Cap/Sales(3y)0.82%
Cap/Sales(5y)1.08%
Profit Quality(3y)322.39%
Profit Quality(5y)287.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.54%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-31.25%
EPS Next Y-27.05%
EPS Next 2Y-9.01%
EPS Next 3Y-0.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%-6.38%
Revenue Next Year-20.78%
Revenue Next 2Y-5.16%
Revenue Next 3Y-2.43%
Revenue Next 5YN/A
EBIT growth 1Y-51.94%
EBIT growth 3Y-13.67%
EBIT growth 5Y-7.51%
EBIT Next Year24.37%
EBIT Next 3Y15.95%
EBIT Next 5YN/A
FCF growth 1Y584.16%
FCF growth 3Y35.54%
FCF growth 5Y0.35%
OCF growth 1Y347.33%
OCF growth 3Y31.82%
OCF growth 5Y-1.02%